Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Children With Various Manifestations of Venous Thrombosis

NCT01684423 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01684423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01684423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Children With Various Manifestations of Venous Thrombosis
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
February 19, 2013
Completion date
September 1, 2016
Enrollment
64 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

venous thrombosis